ValuBit News covers News

Welcome to The Hive! It's nice in here, isn't it? The Hive is a collection of investors, entrepreneurs, thinkers and individuals dedicated to getting a little smarter each day. If you're a fan of value investing, business models, eclectic success and failure stories -- this is your podcast. Our goal is to provide you the highest quality interviews with new twists on old topics. Fresh perspectives on antiquated ideas. Passionate discourse on all things investing. Join us as we strive to improve a little bit each day: https://macro-ops.com/

Written as a peer-reviewed journal for the International Society for Pharmacoeconomics and Outcomes Research and serves as the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Reports on evaluations of medical technologies including pharmaceuticals, biologics, devices, procedures, and other health care interventions. Topics include cost effectiveness/cost utility/cost benefit analysis, health utilities/preferences, health-related quality of life/health status research, medical practice guidelines, disease management, study designs (prospective, retrospective, and modeling) and critical reviews of existing literature.

Value Investing News covers stock market investments. Geared towards investors, who are interested in value stocks. This site offers RSS (Really Simple Syndication).

Value investing is more than an investment strategy -- it's a fundamental way of thinking about finance. Value investing was developed in the 1920s at Columbia Business School by professors Benjamin Graham and David Dodd, MS '21. The authors of the classic text, Security Analysis, Graham and Dodd were the very pioneers of their field and their security analysis principles provided the first rational basis for investment decisions. Despite the vast and volatile changes in the economy and securities markets during the last several decades, value investing has proven to be the most successful money management strategy ever developed. Value investors' success over the second half of the twentieth century proved not only the validity of the value approach, but its preeminence over even the most widely taught and practiced modern investment theory, which was developed in the 1950s and '60s and remains dominant even today. Our mission today is to promote the study and practice of Graham & Dodd's original investing principles and to improve investing with world-class education, research, and practitioner-academic dialogue. In this podcast you will hear from some of the world's greatest investors, their views on the investment management industry, how they developed their investment process and how they see the field changing over time.

Written for investors and helps investors get the most accurate research information available, in any format they choose, and teaches them how to use it to meet their financial objectives.

Written for key decision makers in outlet and value retail chains and the developers of outlet centers. Provides reports on the state of the industry, new developments, industry trends and current events as well as offering in-depth interviews with industry leaders and insightful perspectives on the industry.

Covers financial news. Discusses value investing, hedge funds, banks, asset managers and technology. Sections include: News, Videos, Value Investing, Books, Gurus Per comScore ending December 2013, UVPM was 1,076,081.

Background & Format: Value Walk Premium is a website aimed at readers who are value investors in hedge fund or asset managers. Covers news, quarterly reports, countries' wealth per capita, interviews with CEOs and systemic risks for banks. It also has a sister website Value Walk. There are no advertising opportunities. Monthly Unique Users: The website does not disclose the number

This publication focuses relentlessly on matters of value in cancer through news reporting, feature writing, and commentary from clinicians, payers, and policymakers. That difficult question of whether or not it's worth it because of the impossible costs for cancer medications, and more general conversations involving access, costs, and outcomes, are addressed in Value-Based Cancer Care by drawing together coverage of medicine, policy, economics, business practice, and regulatory matters. Comparative effectiveness research, which addresses value in a very basic way and will become more familiar as healthcare reform kicks in, are covered in this publication. And the real-world implications and application of these developments are considered in analytic, insightful perspectives provided by their Editorial Board.